Remus Pharmaceuticals Limited (NSE:REMUS)

India · Delayed Price · Currency is INR

601.00

-75.90 (-11.21%)

Mar 27, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Pharmaceutical	6.20B	2.13B	451.32M	247.17M	188.08M
Pharmaceutical Growth	191.33%	371.81%	82.59%	31.42%	51.44%
Total	6.20B	2.13B	451.32M	247.17M	188.08M
Total Growth	191.33%	371.81%	82.59%	31.42%	51.44%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
India	2.76B	718.60M	10.73M	15.55M	30.77M
India Growth	284.39%	6596.49%	-30.98%	-49.46%	-
Latin America and The Caribbean	677.60M	552.50M	-	-	-
Latin America and The Caribbean Growth	22.64%	-	-	-	-
Europe	405.00M	75.80M	-	-	-
Europe Growth	434.30%	-	-	-	-
Middle East	13.70M	18.30M	-	-	-
Middle East Growth	-25.14%	-	-	-	-
Africa	23.60M	-	-	-	-
Asia	1.10B	154.40M	-	-	-
Asia Growth	610.30%	-	-	-	-
North America	1.22B	609.80M	-	-	-
North America Growth	100.85%	-	-	-	-
Export	-	-	439.54M	231.62M	153.42M
Export Growth	-	-	89.77%	50.98%	28.72%
Total	6.20B	2.13B	450.27M	247.17M	184.18M
Total Growth	191.33%	372.91%	82.17%	34.20%	54.53%

Source: S&P Global Market Intelligence.